Cancer Research UK’s Drug Development Office announced that Eli Lilly will join its Combinations Alliance to help discover medicines for cancer.
Researchers in Germany have found a new way to exploit the differences between cancer cells and normal cells that could lead to new treatments.
Experts are calling for an urgent change to approaches for treating and researching childhood cancers to continue to save more children.
Combining the experimental drug Avastin (bevacizumab) with the diabetes drug Metformin almost doubles its ability to reduce skin cancer growth, according to a study in Cancer Discovery.
Cancer Research UK scientists have discovered a promising new approach to treat a type of myeloid leukaemia.
Cancer Research Technology – the commercial arm of Cancer Research UK – today announced the appointment of Peter Chambrй as its new chairman.
Senectus Therapeutics has signed a deal to screen a selection of AstraZenecaїs chemical compound library to identify those which trigger a key element of cancer cell ageing ї called senescence.
A powerful new cancer drug discovery database has been launched to speed up the process of bringing drugs from ‘bench to bedside’.
Cancer Research UK and Cancer Research Technology with immatics biotechnologies have launched the first trial of a promising cancer vaccine.